Thrombocytopenic emergencies

Br J Hosp Med (Lond). 2019 Feb 2;80(2):C18-C21. doi: 10.12968/hmed.2019.80.2.C18.

Authors

Laith Tafesh¹, Geoffrey Summerfield²

Affiliations

¹ CT1 Doctor, Department of Haematology, Queen Elizabeth Hospital, Gateshead NE9 6SX.
² Consultant Haematologist, Department of Haematology, Queen Elizabeth Hospital, Gateshead.

PMID: 30747002
DOI: 10.12968/hmed.2019.80.2.C18

No abstract available

MeSH terms

Anticoagulants / adverse effects
Emergencies
Hemolytic-Uremic Syndrome / therapy
Hemorrhage / etiology
Hemorrhage / therapy*
Heparin / adverse effects
Humans
Immunosuppressive Agents / therapeutic use
Plasma Exchange*
Platelet Transfusion*
Purpura, Thrombocytopenic, Idiopathic / complications
Purpura, Thrombocytopenic, Idiopathic / therapy
Purpura, Thrombotic Thrombocytopenic / therapy
Thrombocytopenia / chemically induced
Thrombocytopenia / complications
Thrombocytopenia / therapy*
Thrombotic Microangiopathies / therapy*

Substances

Anticoagulants
Immunosuppressive Agents
Heparin